Skip to content

Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT

Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02968771
Acronym
METS
Enrollment
500
Registered
2016-11-21
Start date
2016-11-30
Completion date
2022-06-30
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease

Keywords

Coronary artery disease, Cardiac perfusion SPECT, Metabolomics

Brief summary

The aim of this study is to analyze metabolomic pattern of patients after cardiac stress in order to detect differences based on the type of stress (physical or pharmacological with adenosine agonists) and result of test (positive or negative for ischemia) and to indentify biochemical markers with prognostic value. Clinical data of enrolled patients regarding demographics, cardiovascular risk factors, pretest probability and previous cardiovascular disease will be recorded. Follow up will be at one, three and five years and will be performed by clinical recordings or phone call when necessary. Blood samples of patients undergoing myocardial perfusion SPECT (Single Photon Emission Computed Tomography) are taken before, immediately after stress and 2h after stress. Serum samples will be analyzed by nuclear magnetic resonance in order to know metabolomic profile.

Detailed description

The aim of this study is to analyze metabolomic pattern of patients after cardiac stress in order to detect differences based on the type of stress (physical or pharmacological with adenosine agonists) and result of test (positive or negative for ischemia) and to indentify biochemical markers with prognostic value. Clinical data of enrolled patients regarding demographics, cardiovascular risk factors, pretest probability and previous cardiovascular disease will be recorded. Follow up will be at one, three and five years and will be performed by clinical recordings or phone call when necessary. Blood samples of patients undergoing myocardial perfusion SPECT are taken before, immediately after stress and 2h after stress. Serum samples will be analyzed by nuclear magnetic resonance in order to know metabolomic profile.

Interventions

OTHERNon intervention

Sponsors

Hospital Universitari Vall d'Hebron Research Institute
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients men or women ≥ 18 years of age * Patients with prescription of cardiac perfusion SPECT

Exclusion criteria

* Patients with loss of consciousness or confuse, not able to read the information and to sign the writting consent * Pregnant women * Patients with dobutamine indications in the stress protocol

Design outcomes

Primary

MeasureTime frameDescription
Result of myocardial perfusion SPECT: positive or negative for angina, ischemia or perfusion defect.2 days
Metabolomic profile on NMR (Nuclear Magnetic Resonance ) analysis of serum sample6 monthOnce all samples analyzed, in order to identify of specific patterns associated to any group (type of test or result of test).

Secondary

MeasureTime frame
Combined end point: Cardiovascular death, Myocardial infarction, Coronary revascularization.1 year
Angina treatment initiation1 year
Metabolomic profile on NMR analysis of serum sample1 year

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026